- Home
- HKPD vs CYTH Comparison
HKPD vs CYTH Comparison
Compare HKPD & CYTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HKPD
- CYTH
- Stock Information
- Founded
- HKPD 2016
- CYTH 1990
- Country
- HKPD Hong Kong
- CYTH United States
- Employees
- HKPD N/A
- CYTH N/A
- Industry
- HKPD Other Pharmaceuticals
- CYTH Biotechnology: Pharmaceutical Preparations
- Sector
- HKPD Health Care
- CYTH Health Care
- Exchange
- HKPD Nasdaq
- CYTH Nasdaq
- Market Cap
- HKPD 15.9M
- CYTH 31.9M
- IPO Year
- HKPD 2025
- CYTH N/A
- Fundamental
- Price
- HKPD $1.23
- CYTH $0.69
- Analyst Decision
- HKPD
- CYTH Buy
- Analyst Count
- HKPD 0
- CYTH 3
- Target Price
- HKPD N/A
- CYTH $0.95
- AVG Volume (30 Days)
- HKPD 90.6K
- CYTH 150.5K
- Earning Date
- HKPD 01-01-0001
- CYTH 03-21-2025
- Dividend Yield
- HKPD N/A
- CYTH N/A
- EPS Growth
- HKPD N/A
- CYTH N/A
- EPS
- HKPD 0.18
- CYTH N/A
- Revenue
- HKPD $16,688,364.00
- CYTH $870,725.00
- Revenue This Year
- HKPD N/A
- CYTH N/A
- Revenue Next Year
- HKPD N/A
- CYTH $24.49
- P/E Ratio
- HKPD $6.39
- CYTH N/A
- Revenue Growth
- HKPD 32.91
- CYTH N/A
- 52 Week Low
- HKPD $1.12
- CYTH $0.55
- 52 Week High
- HKPD $3.79
- CYTH $1.79
- Technical
- Relative Strength Index (RSI)
- HKPD N/A
- CYTH 38.86
- Support Level
- HKPD N/A
- CYTH $0.85
- Resistance Level
- HKPD N/A
- CYTH $0.80
- Average True Range (ATR)
- HKPD 0.00
- CYTH 0.06
- MACD
- HKPD 0.00
- CYTH -0.02
- Stochastic Oscillator
- HKPD 0.00
- CYTH 0.00
About HKPD Hong Kong Pharma Digital Technology Holdings Limited Ordinary shares
Hong Kong Pharma Digital Technology Holdings Ltd operates in two main categories: (i) OTC pharmaceutical cross-border e-commerce supply chain services, conducted through its Hong Kong subsidiary, Joint Cross Border, which it refers to as the Supply Chain Services division, and (ii) OTC pharmaceutical cross-border procurement and distribution, conducted through its Hong Kong subsidiary, V-Alliance, which it referred to as the Procurement and Distribution division. Based in Hong Kong, Joint Cross Border has established itself as a provider of third-party supply chain services in Mainland China's OTC pharmaceutical cross-border e-commerce market.
About CYTH Cyclo Therapeutics Inc.
Cyclo Therapeutics Inc is a clinical-stage biotechnology firm. The company is engaged in developing cyclodextrin-based products for treating neurodegenerative diseases, particularly Niemann-Pick Type C disease (NPC). The company's lead drug candidate, Trappsol Cyclo, has undergone clinical trials for NPC treatment. Operating in one segment, the company focuses on developing and commercializing cyclodextrin-based treatments for rare diseases. Revenue primarily comes from selling cyclodextrins and related products to pharmaceutical and nutritional industries, with Trappsol HPB and Trappsol Fine Chemical being significant contributors.